Insider Transactions in Q1 2024 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$250,000
$10.1 P/Share
|
|
Mar 28
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
|
Mar 28
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-3.69%
|
$400,000
$10.1 P/Share
|
|
Mar 28
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
25,000
-2.26%
|
-
|
|
Mar 21
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-0.62%
|
$88,000
$11.02 P/Share
|
|
Mar 21
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.22%
|
$8,000
$1.06 P/Share
|
|
Mar 19
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.28%
|
$200,540
$10.79 P/Share
|
|
Mar 13
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.03%
|
$275,000
$11.03 P/Share
|
|
Mar 13
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+2.96%
|
$75,000
$2.22 P/Share
|
|
Mar 12
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.05%
|
$250,000
$10.46 P/Share
|
|
Mar 12
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+2.99%
|
$75,000
$2.22 P/Share
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$275,000
$11.56 P/Share
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,319
-3.17%
|
$399,509
$11.86 P/Share
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,924
+1.71%
|
$239,544
$6.94 P/Share
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-0.9%
|
-
|
|
Mar 06
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+0.89%
|
-
|
|
Mar 05
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.28%
|
$240,648
$12.06 P/Share
|
|
Feb 22
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.23%
|
$112,000
$14.89 P/Share
|
|
Feb 22
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.22%
|
$8,000
$1.06 P/Share
|
|
Feb 20
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.14%
|
$240,648
$12.68 P/Share
|
|
Feb 15
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,148
-1.0%
|
$133,776
$12.43 P/Share
|
|
Feb 15
2024
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,379
-0.83%
|
$64,548
$12.43 P/Share
|
|
Feb 15
2024
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,172
-0.6%
|
$86,064
$12.43 P/Share
|
|
Feb 14
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.03%
|
$250,000
$10.71 P/Share
|
|
Feb 14
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.0%
|
$75,000
$2.22 P/Share
|
|
Feb 13
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.09%
|
$225,000
$9.86 P/Share
|
|
Feb 13
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.03%
|
$75,000
$2.22 P/Share
|
|
Feb 09
2024
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,800
-0.43%
|
$28,000
$10.09 P/Share
|
|
Feb 09
2024
|
Tina Marriott Larson President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
233,613
+13.95%
|
-
|
|
Feb 09
2024
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-0.22%
|
$25,120
$10.09 P/Share
|
|
Feb 09
2024
|
Michael Secora Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182,849
+6.94%
|
-
|
|
Feb 09
2024
|
David J Mauro Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,892
-0.77%
|
$18,920
$10.09 P/Share
|
|
Feb 09
2024
|
David J Mauro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,808
+9.89%
|
-
|
|
Feb 09
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,233
-0.29%
|
$32,330
$10.09 P/Share
|
|
Feb 09
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
344,597
+12.18%
|
-
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,272
-5.87%
|
$434,448
$9.22 P/Share
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.66%
|
$62,500
$2.48 P/Share
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.25%
|
-
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.23%
|
-
|
|
Feb 06
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$103,023
$9.3 P/Share
|
|
Jan 25
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.89%
|
$80,000
$10.35 P/Share
|
|
Jan 25
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.86%
|
$8,000
$1.06 P/Share
|
|
Jan 23
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.27%
|
$200,540
$10.58 P/Share
|
|
Jan 17
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.49%
|
$250,000
$10.25 P/Share
|
|
Jan 17
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.59%
|
$75,000
$2.22 P/Share
|
|
Jan 16
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.52%
|
$250,000
$10.45 P/Share
|
|
Jan 16
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.64%
|
$75,000
$2.22 P/Share
|
|
Jan 16
2024
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.63%
|
$180,000
$10.93 P/Share
|
|
Jan 16
2024
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.42%
|
$36,000
$2.22 P/Share
|